A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
Clinical trial NCT03215277 · COMPLETED
Trial details
- NCT number
- NCT03215277
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2020-05-25
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.